Livforsakringsbolaget Skandia’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $126K | Hold |
|
|||||
|
2025
Q1 | $111K | Hold |
|
|||||
|
2024
Q4 | $137K | Sell |
|
|||||
|
2024
Q3 | $437K | Buy |
|
|||||
|
2024
Q2 | $413K | Hold |
|
|||||
|
2024
Q1 | $413K | Hold |
|
|||||
|
2023
Q4 | $395K | Buy |
|
|||||
|
2023
Q3 | $214K | Hold |
|
|||||
|
2023
Q2 | $179K | Hold |
|
|||||
|
2023
Q1 | $192K | Hold |
|
|||||
|
2022
Q4 | $227K | Hold |
|
|||||
|
2022
Q3 | $201K | Sell |
|
|||||
|
2022
Q2 | $244K | Sell |
|
|||||
|
2022
Q1 | $272K | Hold |
|
|||||
|
2021
Q4 | $247K | Buy |
|
|||||
|
2021
Q3 | $115K | Hold |
|
|||||
|
2021
Q2 | $117K | Hold |
|
|||||
|
2021
Q1 | $117K | Hold |
|
|||||
|
2020
Q4 | $115K | Hold |
|
|||||
|
2020
Q3 | $115K | Hold |
|
|||||
|
2020
Q2 | $146K | Buy |
|
|||||
|
2020
Q1 | $61K | Hold |
|
|||||
|
2019
Q4 | $75K | Buy |
|